Last updated: 10 July 2019 at 1:43am EST

Idec Incbiogen Idec Ma Inc ... Net Worth




The estimated Net Worth of Idec Incbiogen Idec Ma Inc ... is at least $15.5 millió dollars as of 27 September 2005. Idec Inc owns over 714,286 units of Sunesis Pharmaceuticals Inc stock worth over $15,491,957 and over the last 19 years Idec sold SNSS stock worth over $0.

Idec Inc SNSS stock SEC Form 4 insiders trading

Idec has made over 1 trades of the Sunesis Pharmaceuticals Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently Idec bought 714,286 units of SNSS stock worth $5,000,002 on 27 September 2005.

The largest trade Idec's ever made was buying 714,286 units of Sunesis Pharmaceuticals Inc stock on 27 September 2005 worth over $5,000,002. On average, Idec trades about 714,286 units every 0 days since 2005. As of 27 September 2005 Idec still owns at least 2,912,022 units of Sunesis Pharmaceuticals Inc stock.

You can see the complete history of Idec Inc stock trades at the bottom of the page.



What's Idec Inc's mailing address?

Idec's mailing address filed with the SEC is 14 CAMBRIDGE CENTER14 CAMBRIDGE CENTER, , CAMBRIDGECAMBRIDGE, MAMA, 0214202142.

Insiders trading at Sunesis Pharmaceuticals Inc

Over the last 19 years, insiders at Sunesis Pharmaceuticals Inc have traded over $89,557,714 worth of Sunesis Pharmaceuticals Inc stock and bought 191,253,594 units worth $84,730,221 . The most active insiders traders include Forest Baskett, Scott D Sandell és Peter J Barris. On average, Sunesis Pharmaceuticals Inc executives and independent directors trade stock every 67 days with the average trade being worth of $14,060,191. The most recent stock trade was executed by Tina Gullotta on 29 May 2020, trading 6,000 units of SNSS stock currently worth $1,980.

Complete history of Idec Inc stock trades at Sunesis Pharmaceuticals Inc

Az érdekelt
Trans.
Tranzakció
Teljes ár
Idec Incbiogen Idec Ma Inc ...
Megvenni $5,000,002
27 Sep 2005


Sunesis Pharmaceuticals Inc executives and stock owners

Sunesis Pharmaceuticals Inc executives and other stock owners filed with the SEC include: